Dysphagia, Lactic Acidosis, Hyperbilirubinemia, Renal Failure, Cirrhosis

Dysphagia, Lactic Acidosis, Hyperbilirubinemia, Renal Failure in Cirrhosis He was discharged with gastroenterology follow-up and ultimately underwent esophagogastroduodenoscopy which demonstrated narrowing of the distal esophagus suggestive of a peptic stricture. Dilation was deferred in favor of resumption of proton pump inhibitor therapy.

Types of Dysphagia, Lactic Acidosis

Oropharyngeal: Characterized by difficulty initiating swallowing and accompanied by choking/coughing, nasopharyngeal regurgitation or aspiration.; Involved anatomy: Tongue, muscles of mastication, soft palate (elevation to close nasopharynx), suprahyoid muscles (elevate larynx), epiglottis (occlude airway), cricopharyngeus muscle (release upper esophageal sphincter). Neurological control predominantly coordinated by cranial nerves (V, VII, IX, X, XII)
Esophageal: Delayed after initiating swallowing and characterized by a sensation of food bolus arresting in transit.; Involved anatomy: Skeletal and smooth muscle along the esophagus and lower esophageal sphincter. Neurological control predominantly coordinated by medulla

Important Historical Features

Difficulty with liquids suggests motility problem
Difficulty with solids only or solids progressing to liquids suggests mechanical obstruction
Identify a history of head and neck surgery or radiation therapy
Identify a personal or family history of connective tissue disorder (scleroderma, RA, SLE) which may be associated with esophageal dysmotility
Review home medications (NSAID, bisphosphonate, potassium chloride, ferrous sulfate)
Immunocompromised patients are at risk for infectious esophagitis (Candida, CMV, HSV) which are generally associated with odynophagia
A history of heartburn may be associated with reflux-mediated complications such as erosive esophagitis, peptic stricture, and adenocarcinoma of the esophagus
Young patients are more likely to be affected by eosinophilic esophagitis
Patient localization of site of obstruction is generally accurate, patients are more accurate at localizing proximal than distal obstructions⁷

Algorithm for the Evaluation of Dysphagia, Lactic Acidosis

Management

Patients who are safely tolerating oral intake can be referred for outpatient gastroenterology evaluation. Admission should be considered for patients at high-risk for aspiration

Portal Venous Gas

Brief HPI

Young male with no significant medical history presenting with progressively worsening right lower quadrant abdominal pain with marked tenderness to palpation and involuntary guarding.

Imaging

portal_venous_gas_0000_Layer-Comp-1

CT Abdomen/Pelvis with Contrast

Inflammatory changes in the right lower quadrant concerning for ruptured appendicitis with approximately 9 cm abscess.
Gas in the liver likely representing portal venous gas which can be seen in the setting of appendicitis vs less likely secondary to bowel ischemia.

Differentiation between Portal Venous Gas and Pneumobilia

Gastrointestinal Bleeding

Evaluation and Management of Gastrointestinal Bleeding

Key Historical Features

Quantity: Patient’s estimate; Symptoms suggestive of anemia/volume depletion: (pre)syncope, dyspnea
Appearance/Location: Distinguish upper from lower GI bleding
PMH: Prior episodes and source; History of aortic aneurysm graft; Comorbidities: presence of CAD, CHF, liver disease or diabetes increases mortality
Medications/substance use: Gastrotoxic, anti-coagulants, anti-platelet agents; Alcohol abuse

Key Physical Findings

Vital signs: Tachycardia or hypotension
Eyes: Conjuntival pallor suggests anemia; Scleral icterus suggests liver disease
Abdomen: Hyperactive bowel sounds may be present in UGIB (blood is cathartic); Epigastric tenderness to palpation suggests PUD; Diffuse tenderness suggests bowel ischemia, obstruction/ileus, or perforation
Rectal (digital, anoscopy): May reveal fissures, hemorrhoids or polyps

Labs/Diagnostic Tests

CBC: consider transfusion for Hb <8-10g/dL particularly in elderly or those with CAD
BMP: BUN:creatinine > 36 in the absence of renal failure suggests UGIB
PT/PTT/INR: coagulopathy
Lactate: elevated in bowel ischemia or systemic hypoperfusion
T&S or T&C
ECG: screen for myocardial ischemia

Blatchford Scoring System

ITEM	VALUE	POINTS
BUN	18-22	2
	22-28	3
	28-70	4
	>70	6
Hb (male)	12-13	1
	10-12	3
	<10	6
Hb (female)	10-12	1
Hb (female)	<10	6
SBP	100-109	1
	90-99	2
	<90	3
Other	HR > 100	1
	Melena	1
	Syncope	2
	Liver disease	2
	Heart failure	2

Nausea and Vomiting

Pathophysiology of Nausea and Vomiting

Complications of Nausea and Vomiting

Hypovolemia: activates RAAS
Metabolic alkalosis: loss of hydrogen ions in vomitus
Hypokalemia: RAAS promotes sodium retention and potassium excretion
Esophageal injury: Mallory-Weiss tear, Boerhaave syndrome
Aspiration

Key Historical Findings

Duration of vomiting: Acute: Episodic and occurring for <1 week. Suggestive of obstructive, toxic/metabolic, infectious, ischemic or neurologic process.; Chronic: Episodic and occurring for >1 month. Suggestive of partial obstruction, motility disorder or neurologic process.
Onset: Acute onset: suggests pancreatitis, gastroenteritis, or cholecystitis.
Timing: Post prandial: delayed >1 hour suggests gastric outlet obstruction or gastroparesis.
Contents: Bile: presence of bile suggests patent connection between duodenum and stomach (no GOO); Undigested food: suggests upper GI tract process (achalasia, esophageal stricture, Zenker); Feculent: suggests distal bowel obstruction
Associated symptoms: Headache: suggests elevated ICP

Causes of Nausea and Vomiting

Abdominal Pain

Pathophysiology of Abdominal Pain

Visceral: distension of hollow organs or capsular stretch of solid organs.
Somatic: parietal peritoneal irritation
Referred
- Extra-abdominopelvic
  - Epigastric: inferior MI
  - Pelvic: hip
  - Abdominal: lower lobe pneumonia/infarction
- Abdominopelvic
  - Shoulder: diaphragmatic irritation (ex. perforated duodenal ulcer, splenic pathology)
  - Mid-back: aortopathy, pancreatitis
  - Flank: renal pathology
  - Low back: uterus, rectum

Concerning Historical Features

Elderly: increased probability for severe disease with poor clinical diagnostic accuracy
Immunocompromised: HIV/AIDS, uncontrolled diabetes, chronic liver disease, chemotherapy, other immunosuppression
Pain preceding nausea/vomiting: increased likelihood of surgical process
Abrupt onset, duration <48h, constant timing
Prior abdominal surgical history: consider bowel obstruction
No prior episodes of similar pain
Recent antibiotic or steroid use: may mask signs of infection
Cardiac risk factors (HTN, vascular disease, atrial fibrillation: increased risk for mesenteric ischemia or aortic aneurysm
Heavy NSAID use or anticoagulation: increase concern for gastrointestinal bleeding

Imaging

Plain film reserved for those who would otherwise not undergo CT. XR abdomen for bowel obstruction or radiopaque foreign body.
CT abdomen/pelvis with IV contrast, particularly if elderly or immunocompromised.
Ultrasound preferred for hepatobiliary pathology
Bedside ultrasound for identification of IUP, free intraperitoneal fluid, cholecystitis, CBD dilation, ascites, hydronephrosis, aortopathy, volume status.

Causes of Abdominal Pain

Lactic Acidosis

HPI

59F with a reported history of congestive heart failure, presenting with intermittent chest discomfort for three days.

She characterized this discomfort as “heartburn”, describing a mid-epigastric burning sensation radiating up her neck, not associated with exertion, lasting 1-2 hours and resolving with antacids. The patient has poor exercise tolerance at baseline and for the past several years has been able to ambulate only short distances around her home, and states that these symptoms have been worsening in the past week. She denies chest pain on exertion, orthopnea or paroxysmal nocturnal dyspnea. She states that she was diagnosed with congestive heart failure five years ago, but was never prescribed medications.

On further questioning, the patient reports several weeks of mouth and lip pain which has limited oral intake, though no dysphagia to solids or liquids. She otherwise denies fevers/chills, abdominal pain, nausea/vomiting, cough, changes in urinary or bowel habits.

In the emergency department, the patient was noted to have an elevated serum troponin, though ECG showed no changes of acute ischemia/infarction.

PMH:

Congestive heart failure

PSH:

None

FH:

Mother with diabetes
Father with MI at age 65

SHx:

4-5 drinks of alcohol/day
No tobacco or drug use

Meds:

None

Allergies:

NKDA

Physical Exam

VS:	T	37.4	HR	106	RR	18	BP	145/82	O2	100% RA
Gen:	Morbidly obese female, lying in bed, in no acute respiratory distress, speaking in complete sentences.
HEENT:	Dry, cracked lips, slightly erythematous, otherwise moist mucous membranes, poor dentition. Mild scleral icterus. No cervical lymphadenopathy.
CV:	Rapid rate, regular rhythm, normal S1/S2, II/VI systolic ejection murmur at LUSB, no radiation appreciated. No jugular venous distension.
Lungs:	Clear to auscultation in posterior lung fields bilaterally, no crackles appreciated.
Chest:	Well-circumscribed erythematous patch in folds beneath left breast, no underlying fluctuance, no significant tenderness to palpation. On contralateral breast, some hyperpigmentation but no erythema.
Abdomen:	Obese, non-tender, non-distended. Patch of erythema below pannus, mildly tender to palpation.
Ext:	Bilateral lower extremities with marked edema and overlying scaly plaques, some slightly ulcerated weeping serous fluid. Peripheral pulses are difficult to palpate, capillary refill difficult to assess.

You Might Also Like Diet for Thick Hair, Way of Grow Hair to More Thicker

Labs/Studies

CBC: 11.1/11.1/34.5/212 (MCV 114.2)
BMP: 140/4.5/97/20/10/1.14/64
Anion Gap: 23
LFT: AST: 73, ALT: 26, AP: 300, TB: 4.6, DB: 2.1, Alb: 3.0, INR 1.3
BNP: 158
Troponin: 1.284

Sinus tachycardia, LVH, secondary repolarization abnormalities

Imaging

CT Pulmonary Angiography
No evidence of central pulmonary embolism, thoracic aortic dissection, or thoracic aortic aneurysm. Evaluation of the peripheral vessels is limited due to motion artifact. No focal consolidation or pneumothorax.

CT Abdomen/Pelvis non-contrast
No evidence of intra-abdominal abscess or definite source of infection. Marked hepatic steatosis.

CT Lower Extremity non-contrast
Diffuse circumferential subcutaneous edema involving both lower extremities from the level of the mid thighs distally through the feet. There are bilateral subcutaneous calcifications which are likely venous calcifications in the setting of chronic venous stasis disease. There is some overlying skin thickening.

TTE
There is moderate concentric left ventricular hypertrophy with hyperdynamic LV wall motion. The Ejection Fraction estimate is >70%. Grade I/IV (mild) LV diastolic dysfunction. No hemodynamically significant valve abnormalities.

US Abdomen
Hepatomegaly, echogenic liver suggesting fatty infiltration. Moderately blunted hepatic vein waveforms suggesting decreased hepatic parenchymal compliance.

Assessment/Plan

The patient was admitted to the cardiology service for management of NSTEMI and evaluation of undiagnosed CHF. She was started on a heparin continuous infusion. In addition, a CT pulmonary angiogram was obtained to evaluate for pulmonary embolism as an explanation of her progressive dyspnea on exertion. No PE, consolidation or effusion was identified.

Despite the patient’s reported history of congestive heart failure, there was no evidence that her symptoms were a result of an acute exacerbation with only a mildly elevated BNP but no jugular venous distension or evidence of pulmonary edema. The patient’s significant lower extremity edema was more suggestive of chronic venous stasis.

One notable laboratory abnormality that was explored was her elevated anion gap metabolic acidosis. Studies submitted included serum lactate, salicylates, osmolarity, CK, and urinalysis for ketonuria. This evaluation was notable for an elevated serum lactate of 13.2mmol/L and an arterial blood gas that showed adequate respiratory compensation (and no A-a gradient). Given the patient’s modest leukocytosis (with neutrophil predominance), and tachycardia, the concern for sepsis was increased though the source remained unclear. Prominent possibilities included a skin and soft-tissue infection vs. less likely intra-abdominal source though the patient’s physical examination was not suggestive of a process that would produce such a substantial lactic acidosis. Blood cultures were drawn and the patient was started on empiric antibiotics for the suspected sources. In addition, the patient was cautiously volume resuscitated given her reported history of CHF while pending a transthoracic echocardiogram to evaluate cardiac function. Additional imaging including CT abdomen/pelvis and lower extremities was obtained (though without contrast due to the patient’s recent exposure), and no obvious source was identified.

Over the next two days, the patient’s serum lactate downtrended to normal range, as did the serum troponin. A transthoracic echocardiogram showed an LVEF >70% with mild concentric hypertrophy and diastolic dysfunction. Blood and urine cultures were without growth.

Additional issues managed during the hospitalization included elevated serum transaminases (AST > ALT), conjugated hyperbilirubinemia and evidence of decreased hepatic synthetic function with hypoalbuminemia and elevated INR. Given the patient’s history of EtOH use, as well as other corroborating findings including macrocytic anemia, hypomagnesemia, folate and B12 deficiency, this was attributed to alcoholic hepatitis(discriminant function <32). Infectious hepatitis serologies were negative. The patient was started on nutritional supplements. Finally, the patient persistently complained of lip and oral mucosal pain. Examination was without discrete lesions but some mucosal redness was identified. Despite poor dentition, there was no evidence of abscess and HSV/HIV testing was negative. This was thought to be stomatitis caused by her identified nutritional deficiencies.

Differential Diagnosis of Elevated Serum Lactate

Algorithm for Evaluation of Acidemia

Algorithm for Evaluation of Alkalemia

Biliary Duct Dilationmonth, he denies abdominal pain

Ultrasound

Liver

CT Abdomen/Pelvis

IM-0001-0011

Markedly dilated intrahepatic biliary ducts, common bile duct and pancreatic duct.
Ill-defined fullness in the pancreatic head consistent with pancreatic adenocarcinoma vs. noncalcified obstructing biliary stone.

Differential Diagnosis of Biliary Duct Dilation

Hepatic Abscess

42M with 1.5 weeks of fevers. Initially presented to ER 1wk ago and treated for possible otitis media, however follow-up ENT appointment showed no evidence of OM on exam. Fevers persisted and he developed headaches and went to urgent care where a CT head and LP were negative. A mild elevation of serum transaminases was noted and the following CT abdomen/pelvis was obtained. He denied GI symptoms.

Imaging

Hepatic Abscess - Axial

Hepatic Abscess – Axial

– 7.4 cm cystic lesion in the inferior right lobe of the liver most consistent in appearance with hepatic abscess.
– Multiple calcified gallstones with a 10 mm gallstone in the neck of the gallbladder or possibly in the cystic duct.

Hepatic Abscess - Coronal

Hepatic Abscess – Coronal

Assessment & Plan

Liver abscess: likely pyogenic s/p CT-guided drainage with 60cc purulent fluid removed. Gram stain showed GNR and WBC’s, culture grew Klebsiella pneumonia. Treated with ceftriaxone 2g IV q24h, metronidazole 500mg PO TID.

Differential Diagnosis of Hepatic Abscess

Alcoholic Hepatitis

HPI

43 year-old female with a history of alcohol abuse and alcoholic hepatitis, presenting after referral from breast clinic for abnormal labs (notable for total bilirubin 18.1). The patient was well until two weeks ago when she noted increasing fatigue associated with morning nausea/vomiting (non-bloody) as well as yellowing of skin and eyes. She also reports darkening of urine, but no dysuria, change in volume of urine, or visible blood. She also denies fevers/chills, increased abdominal girth, abdominal pain, changes in bowel habits or bloody/dark stools.

She reports drinking 1 pint of vodka daily for the past 15 years, and perhaps more in the past 3 weeks. Her last drink was in the morning on the day of admission, she denies any history of seizures and reports withdrawal symptoms (tremor, nausea) relieved with more alcohol. She currently denies anxiety/agitation, tactile/visual/auditory hallucinations.

The patient was in breast clinic for evaluation of a painful breast mass which developed after biopsy of a lesion which was ultimately found to be benign. The patient noted the mass was growing in size and becoming more painful over the past month.

PMH

EtOH abuse
Alcoholic hepatitis

PSH

None

FH

No family history of breast/gynecologic malignancy.
Mother with history of stroke. Father with diabetes.

SHx

Lives alone.
Denies current or previous tobacco/drug use. Drinks 1 pint of whiskey daily for the past 15 years.
Not currently sexually active, no history of STI.

Meds:

None

Allergies

NKDA

Physical Exam

VS:	T	98.9	HR	104	RR	19	BP	117/67	O2	99% RA
Gen:	Well-appearing obese female in no acute distress
HEENT:	PERRL, marked scleral icterus, sublingual icterus, MMM, no lesions
CV:	Tachycardia, regular rhythm, normal S1/S2, no M/R/G
Lungs:	CTAB, no crackles/wheezing
Abd:	+BS, soft, non-distended, liver edge palpated 6cm below costal margin, irregular texture slightly tender to palpation, spleen not palpated, no fluid wave or shifting dullness, no rebound/guarding.
Ext:	Warm, well-perfused, 2+ pulses (DP/PT), slight yellowing.
Skin:	Vascular spiders on anterior chest, left breast with 5x5cm ecchymosis and tender underlying mass, no erythema, warmth, skin dimpling, nipple discharge.
Neuro:	AAOx4, CN II-XII intact, no tremor noted, gait normal.

Labs/Studies

1mo prior to admission:

AST/ALT/AP/TB: 444/77/234/2.5

Day 1:

AST/ALT/AP/TB: 185/61/184/18.1
PT/PTT/INR: 14.7/37.0/1.2

Day 4:

AST/ALT/AP/TB: 142/50/153/25.5
PT/PTT/INR: 20.1/38.9/1.7

You Might Also Like Bad Breath; Types, Causes, Symptoms, Diagnosis, Treatment

Imaging

Abdominal US

Markedly echogenic and enlarged liver with a nodular surface of cirrhosis.
Markedly blunted hepatic vein waveforms commonly seen due to decreased hepatic parenchymal compliance although other etiologies causes of obstruction to hepatic venous outflow.
Splenomegaly.

Assessment/Plan

44F hx EtOH abuse, alcoholic hepatitis, presenting with acute alcoholic hepatitis.
# Alcoholic hepatitis: Rapid onset of jaundice, tender hepatomegaly, and elevation of transaminases (AST > ALTx2) in the setting of chronic alcohol use suggestive of alcoholic hepatitis. Initial Maddrey discriminant hepatic function (mDH) score 37 suggestive of severe disease with high short-term mortality. Initiated trental 400mg p.o. t.i.d.
# EtOH withdrawal: Last drink <24h ago, monitor for signs of withdrawal, treat with Ativan per withdrawal protocol. # Cirrhosis: Newly diagnosed on abdominal ultrasound. Complicated by coagulopathy, and likely portal hypertension given splenomegaly/thrombocytopenia. Plan for outpatient screening EGD and continued GI follow-up. # Breast mass: Likely hematoma 2/2 biopsy associated given increased size associated with progression of coagulopathy/thrombocytopenia. Outpatient ultrasound and follow-up scheduled. # Anemia: Macrocytic, potentially related to vitamin deficiency vs. bone-marrow suppression associated with chronic alcohol use. Start thiamine/folate/multivitamin. # FEN/GI/PPx: Encourage p.o. intake (2g sodium restriction), continue ondansetron p.r.n. nausea/vomiting, obtain nutrition consult.

Hospital Course

Patient’s liver function continued to decline as evidenced by worsening coagulopathy and increased serum bilirubin. mDH had increased to 58 by day four of hospitalization and steroids were added.

Pathophysiology of Alcoholic Hepatitis

Ethanol promotes translocation of bacterial components (lipopolysaccharide) across the intestinal wall, into the portal venous system and liver. These trigger a local and systemic inflammatory response which leads to hepatocellular injury and systemic effects such as fever, anorexia and weight loss.

Evaluation of Alcoholic Hepatitis

Clinical features

Rapid onset jaundice
Tender hepatomegaly
Fever
Ascites
Proximal muscle loss
Encephalopathy

Labs

AST > ALT (x2), generally < 300IU/mL
Leukocytosis
↑Total serum bilirubin
↑INR
↑Creatinine associated with poor prognosis

Other studies

Screening for infection: PNA, UTI, SBP
Abdominal US to evaluate hepatic abscess, HCC, extrahepatic biliary obstruction

Management of Alcoholic Hepatitis

Grading Severity

Maddrey’s discriminant function
Glasgow score
Lille score (assess response to corticosteroids after 1wk)

Treatment

Immediate and lifetime abstinence from alcohol
Trental 400mg p.o. t.i.d.
Prednisolone 40mg p.o. daily (controversial, some benefit in subgroup with Maddrey > 32)
Ascites: Sodium restriction, diuretics
Encephalopathy: Lactulose, rifaximin
Hepatorenal syndrome: albumin, vasopressors
Nutritional support

Interpretation of Liver Function Tests

DISORDER	BILIRUBIN	AST/ALT	AΦ	ALBUMIN	PT
Hemolysis Gilbert	↑(indirect) No bilirubinuria	–	–	–	–
Acute hepatocellular necrosis	↑	↑ALT > AST > 500IU	↑	–	– (poor prognosis if elevated)
Chronic liver disease	↑	↑< 300IU	↑	↓	↑
Alcoholic hepatitis	↑	↑AST:ALT > 2	↑	↓	↑
Intra- extra-hepatic cholestasis	↑	↑< 500IU	↑↑(>4x normal)	–	–

Features of Components of Liver Function Tests

Renal Failure in Cirrhosis

CC:

Consult for acute kidney injury

HPI:

63M with a history of liver cirrhosis of cryptogenic etiology, portal vein thrombosis, and esophageal varices s/p banding (2011) who was admitted to an OSH for altered mental status and hypotension requiring dopamine and was transferred to this facility for a higher level of care.

The nephrology service was consulted for elevated serum creatinine concerning for AKI. The patient has a baseline creatinine of 1.1 (3/2013), 1.9 on transfer and continued worsening to peak of 2.6 today.

PMH:

Asthma
COPD
Cirrhosis (PVT, encephalopathy)
Inguinal hernia (recurrent)

PSH:

Appendectomy
Bilateral inguinal hernia repair

FH:

Non-contributory

SHx:

Married
Denies t/e/d use

Meds:

albumin 25g i.v. q.6.h.
erythromycin 1,000mg p.o. q.1.h.
fluticasone-salmeterol 1 puff b.i.d.
lactulose 45g p.o. q.6.h.
neomycin 1,000mg p.o. q.1.h.
pantoprazole 40mg i.v. daily
rifaximin 550mg p.o. b.i.d.
sodium benzoate 5g p.o. b.i.d.

Allergies:

Sulfa

Physical Exam

VS:	T	37.4	HR	90	RR	15	BP	86/48	O2	97% RA
Gen:	Chronically ill-appearing.
HEENT:	PERRL, scleral icterus, MMM
CV:	RRR
Lungs:	CTAB
Abd:	+BS, soft, non-tender, non-distended
GU:	Large ascites filled scrotum, testicles/inguinal canal not easily palpated
Ext:	Warm, well-perfused
Skin:	No palmar erythema, no vascular spiders
Neuro:	AAOx4, CN II-XII grossly intact

Labs:

BMP: 134/4.5/103/20/41/3.0/106 (Ca 9.3, Mg 3.7, PO4 2.4)
LFT: AST 89, ALT 33, TB 26.6, CB 16.1, Alb 2.7
NH4 167

Imaging:

Pleural Effusion

Large right pleural effusion with underlying compressive atelectasis.

Cirrhosis and Portal Hypertension

Shrunken/nodular liver with sequelae of portal hypertension including perisplenic collaterals, and splenomegaly.

SMV Thrombosis

Near-total thrombosis of the portal vein extending down to superior mesenteric vein.

B/L Inguinal Hernias

Large volume abdominal ascites with a large amount of fluid extending into the bilateral inguinal canals.

Large Right Inguinal Hernia

Large volume abdominal ascites with a large amount of fluid extending into the bilateral inguinal canals

Assessment/Plan

63M with a history of liver cirrhosis of cryptogenic etiology, recently with hypotension prior to transfer to this facility and increase in creatinine from 1.9-3.0 on current admission (from baseline 1.1).

These findings indicate acute kidney injury, likely hepatorenal syndrome vs. acute tubular necrosis 2/2 prolonged hypotension. Plan to discontinue diuretics and start albumin challenge (1g/kg/day divided q6h x2d). Will also check UA, urine Na/cr/urea/eos, renal US (evaluate obstruction, kidney size). Start midodrine/octreotide for underlying HRS.

Neuro: Intermittent confusion. Lactulose, rifaximin, benzoate.
Resp: 2L NC. ABG 7.36/51/87/27.7/+2. CXR: Large R effusion.
CV: Levo 0.075. Midodrine 15 TID. MAPs 60, HR 80s.
GI: NPO/NGT. TPN.
Renal: See above.
Heme: Coagulopathy, keep INR <2.5
ID: Afebrile. No abx.
Endo: Euglycemic

Renal Failure in Cirrhosis

Renal failure in cirrhosis is associated with higher mortality both before and after transplant. The main causes of renal failure in cirrhosis are detailed below, with particular attention to an entity unique to cirrhosis: the hepatorenal syndrome.¹

DISORDER	PATHOGENESIS	DIAGNOSIS	MANAGEMENT
HRS	Dilation of splanchnic arteries initially compensated by increased CO eventually decompensates with activation of mechanisms to preserve ECBV (RAAS, SNS, ADH) leading to fluid retention (ascites, edema) and renal failure due to intrarenal vasoconstriction.Bacterial translocation and the resulting inflammatory response may contribute to splanchnic vasodilation (through production of vasoactive factors like NO).	Serum creatinine > 1.5mg/dl- Not reduced with 1g/kg albumin No confounding factors (2d off diuretics, no nephrotoxic agents, no shock, no e/o intrinsic renal disease) Type 1: doubling creatinine > 2.5mg/dL in <2wk Type 2: stable, slower progression	Vasoconstrictor therapy- Albumin Portasystemic shunting Renal replacement therapy Prevention Norfloxacin Albumin
Intrinsic renal	Some causes of liver disease are also associated with intrinsic renal pathology (ex. GN associated with HBV, HCV).	Proteinuria, hematuria Renal bx Active urinary sediment	Antiviral therapy if appropriate
Pre-renal AKI	Hemorrhage (GIB), fluid losses (excess diuresis, diarrhea from lactulose).	Suspected from patient history Low FENa, bland urine sediment	Hemorrhage: replace volume with fluids, blood products. Control bleeding. Discontinue diuretics, administer fluids if tolerated
ATN	Severe ischemic or toxic (NSAID’s, nephrotoxic medications)	Renal tubular epithelial cells favor ATN (granular casts common in ATN, HRS)	Withdraw therapy Avoid nephrotoxic agents

Pathophysiology of Hepatorenal Syndrome

Evaluation

The evaluation of suspected renal failure in patients with cirrhosis involves assessment of renal function for evidence of acute impairment, as well as analaysis of urine for protein or active sediment to suggest intrinsic renal disease (possibly warranting renal ultrasonography or biopsy). Additionally, patients should be evaluated for evidence of bacterial infection including assessment of ascites if present as SBP produces a more severe form of the inflammatory vasodilation mechanism suspected to play a role in HRS.

Treatment

For renal failure not caused by the hepatorenal syndrome, identification and management of the underlying cause is critical (intrinsic renal disease, hypovolemia/hemorrhage, nephrotoxicity, infection). For suspected HRS, management is dependent on the acuity and setting. In the intensive care unit, vasoconstrictor therapy (norepinephrine, vasopressin) in association with albumin is effective in the treatment of HRS.^2,3 In less acute settings, a combination of midodrine, octreotide and albumin improves renal function and is associated with lower short-term mortality.⁴ Alternatives for patients who do not respond to medical therapy include TIPS, dialysis and transplant.

You Might Also Like Schedule Change Gabapentin; FDA Recomendation for gabapentin

Summary

Renal failure in ESLD is due to the causes, complications or management of cirrhosis and has important implications, with HRS in particular offering the worst prognosis.⁵ Early recognition and management is critical to improving outcomes

Hyperbilirubinemia

CC:

Yellow eyes

HPI:

51yo AA male with hx DM, HTN, sarcoidosis presents with yellowing of eyes and full-body itching x3wks. This was associated with dark urine and loose, light-brown stools. He denies N/V, abdominal pain, PO intolerance, F/C, recent travel, weight loss. He states that this has not occurred in the past, and he does not have any prior history of post-prandial abdominal pain.

PMH:

DM
HTN
Sarcoidosis

PSH:

None

FH:

No GI malignancy

SHx:

No tobacco or drug use, 10 years of 10 drinks/wk stopped 1yr ago

Meds:

lisinopril 20mg p.o. daily
pioglitazone 15mg p.o. daily
sitagliptin 100mg p.o. daily
lansoprazole 15mg p.o. daily

Allergies:

Vicodin (rash)

Physical Exam

VS:	T	97.9	HR	102	RR	12	BP	128/68	O2	99% RA
Gen:	WA, NAD
HEENT:	Marked scleral icterus, PERRL, yellowing of posterior oropharynx and floor of mouth, MMM, no cervical lymphadenopathy
CV:	RRR, S1/S2 normal, no murmurs
Lungs:	CTAB with good air movement
Abd:	Obese, +BS, soft, NT/ND, no rebound/guarding, no palpable organomegaly, negative Murphy
GU:	No inguinal lymphadenopathy
Ext:	Warm, well-perfused, no LE edema, peripheral pulses 2+
Skin:	No visible skin lesions
Neuro:	AAOx3

Labs:

CBC: 16/12.4/35.1/281
LFT: AST 281, ALT 302, AP 264, T.bili 22.1, D.bili 16.8

Studies:

RUQ US: Biliary sludge, no stones, no GBW thickening, no pericholycystic fluid
ERCP: 3cm stricture of distal CBD, biopsies taken

Assessment/Plan

51AAM w/DM, HTN, sarcoidosis with 3wks painless jaundice. Obstructive pattern along with only modest elevation of liver enzymes suggests the obstruction is likely extrahepatic which was supported by ERCP finding of a distal CBD stricture. Patient has no history of prior instrumentation to cause iatrogenic stricture, and while sarcoidosis is associated with cholestatic complications (portal granulomas), pathology from biopsy showed papillary adenocarcinoma. The patient was scheduled for surgery with a plan for initial laparoscopic survey of the abdomen followed by Whipple if no evidence of widespread disease.

Imaging

ERCP

3cm stricture of distal CBD

MRCP

Filling defect in the common bile duct with marked dilatation of the common duct and intrahepatic ducts.
Findings may reflect an intraluminal mass or stone.

CT Abdomen/Pelvis

Common bile duct stent present
Expected air in the intrahepatic biliary tree and mild biliary ductal dilatation

Differential Diagnosis of Hyperbilirubinemia

Evaluation of Hyperbilirubinemia

Nausea and Vomiting

HPI:

57yo male with a history of HTN, DM, and MI s/p stent in 2011 presenting with nausea/vomiting and hypotension. The patient had one episode of non-bloody, non-bilious emesis approximately 6 hours ago. He felt unwell so a friend checked his blood pressure which was found to be 75/50, prompting a visit to this emergency department.
The patient’s emesis came 2 hours following a normal meal (frozen dinner), and was associated with chills/sweats but no abdominal pain. The patient had some associated shortness of breath (baselines), but no chest pain, arm or jaw pain, or palpitations.

He states that these symptoms are unlike what he experienced during his MI. He reported no change in bowel or urinary habits.

PMH:

HTN
DM
CAD
MI
Hyperlipidemia

PSH:

Stent placement (2011)
Right knee neuroma excision (2012)

FH:

Non-contributory

SHx:

No current t/e/d
80 pack-year smoking history

Meds:

carvedilol 6.25mg p.o. b.i.d.
metformin 1000mg p.o. b.i.d.
atorvastatin 20mg p.o. daily
aspirin 81mg p.o. daily

Allergies:

NKDA

Physical Exam

VS:	T	98.4	HR	65	RR	17	BP	96/56	O2	95% 2L NC
Gen:	No acute distress, speaking in complete sentences
HEENT:	PERRL, MMM no lesions, no cervical lymphadenopathy
CV:	RRR, normal S1/S2, no murmurs, no extra heart sounds, no jugular venous distension
Lungs:	CTAB, no crackles
Abd:	+BS, soft, NT/ND, no rebound/guarding, no organomegaly
Ext:	Warm, well-perfused, peripheral pulses equal b/l, no LE edema
Neuro:	AAOx3

Labs

EKG: normal sinus rhythm, anterior lead q-waves suggestive of old infarct, no T/ST changes
Troponin: <0.01
CBC: 7.4/15.5/47/228
BMP: 139/5.1/107/26/8/1.19/112 (baseline creatinine 1.06 in 2/2013)

Studies

CXR: no effusion, no cardiomegaly, no focal consolidation
Bedside US: normal cardiac wall motion, estimated EF 40-45%, retrohepatic IVC collapses with respiration

Assessment/Plan

57M hx HTN, DM, MI s/p stent presenting with nausea/vomiting x1 and hypotension. The patient’s symptoms and history were concerning for acute myocardial infarction; however, early EKG and troponins were reassuring. Additionally, the absence of characteristic physical findings that would be associated with an acute MI causing cardiogenic shock (elevated JVP, extra heart sounds, pulmonary crackles) were not present. Evidence of end-organ damage was also absent.

Other potential causes for nausea/vomiting include SBO, however, the patient reported normal BM’s and has no history of abdominal surgery. Though occurring after a meal, a single episode of emesis without associated abdominal pain lowers suspicion for biliary disease. This patient’s emesis is most likely due to acute gastroenteritis.

Given the evidence of hypovolemia on bedside ultrasound, the patient was bolused with a total of 1.5L NS and noted symptomatic improvement as well recovery of blood pressure.

Differential Diagnosis of Nausea/Vomiting

Pathophysiology

Nausea: Sensation associated with increased gastrointestinal motility (tachygastria).
Vomiting:
- Chemoreceptor trigger zone (area postrema of 4^th ventricle): sensitive to drugs/toxins (emetics, radiation), neurotransmitters. Located outside BBB.
- Nucleus tractus solitaries (medulla): pattern generator for vomiting, receives vagal input from GI tract and nociceptive stimuli from peripheral nervous system – transmits to hypothalamus, limbic system and cortex. Stimulated by tickling the back of the throat, gastric distention, and vestibular input.

Important history/physical associations

Abdominal pain: suggests organic disease, affected organ dependent on location of pain. (See figure)
Abdominal distension: suggests bowel obstruction.
Heartburn: suggests GERD.
Vertigo/nystagmus: suggests vestibular etiology.
Positional/projectile: suggests neurogenic etiology.